References
- Kurz A , SesslerDI . Opioid-induced bowel dysfunction: pathophysiology and potential new therapies . Drugs63 ( 7 ), 649 – 671 ( 2003 ).
- Bell TJ , PanchalSJ , MiaskowskiC , BolgeSC , MilanovaT , WilliamsonR . The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1) . Pain Med.10 ( 1 ), 35 – 42 ( 2009 ).
- Coyne KS , LocasaleRJ , DattoCJ , SextonCC , YeomansK , TackJ . Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review . Clinicoecon. Outcomes Res.6 , 269 – 281 ( 2014 ).
- Hjalte F , BerggrenAC , BergendahlH , HjortsbergC . The direct and indirect costs of opioid-induced constipation . J. Pain Symptom Manage.40 ( 5 ), 696 – 703 ( 2010 ).
- Leslie J , BellT , AnnunziataK , FreedmanD . Opioid-induced constipation compromises pain management and impacts patients quality of life . Anesthesiology.105 ( Abstract ), 1490 ( 2006 ).
- Penning-Van Beest FJ , Van Den HaakP , KlokRM , PrevooYF , Van Der PeetDL , HeringsRM . Quality of life in relation to constipation among opioid users . J. Med. Econ.13 ( 1 ), 129 – 135 ( 2010 ).
- Yuan C-S , PappagalloM . Handbook of Opioid Bowel Dysfunction . Haworth Medical Press: Haworth Reference Press , NY, USA ( 2005 ).
- Kumar L , BarkerC , EmmanuelA . Opioid-induced constipation: pathophysiology, clinical consequences, and management . Gastroenterol. Res. Pract.2014 , 141737 ( 2014 ).
- Manchikanti L , AbdiS , AtluriSet al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2 – guidance . Pain Physician15 ( 3. Suppl. ), S67 – S116 ( 2012 ).
- Pappagallo M . Incidence, prevalence, and management of opioid bowel dysfunction . Am. J. Surg.182 ( 5A Suppl. ), 11S – 18S ( 2001 ).
- Leppert W . The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities . Contemp. Oncol. (Pozn).16 ( 2 ), 125 – 131 ( 2012 ).
- Panchal SJ , Muller-SchwefeP , WurzelmannJI . Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden . Int. J. Clin. Pract.61 ( 7 ), 1181 – 1187 ( 2007 ).
- Ahmedzai SH , BolandJ . Constipation in people prescribed opioids . BMJ Clin. Evid.2010 , 2407 ( 2010 ).
- Brenner DM , CheyWD . An evidence-based review of novel and emerging therapies for constipation in patients taking opioid analgesics . Am. J. Gastroenterol. Suppl.2 ( 1 ), 38 – 46 ( 2014 ).
- Cook SF , LanzaL , ZhouXet al. Gastrointestinal side effects in chronic opioid users: results from a population-based survey . Aliment. Pharmacol. Ther.27 ( 12 ), 1224 – 1232 ( 2008 ).
- Coyne KS , CurrieBM , HolmesWC , CrawleyJA . Assessment of a stool symptom screener and understanding the opioid-induced constipation symptom experience . Patient.8 ( 4 ), 317 – 327 ( 2015 ).
- Johannes CB , LeTK , ZhouX , JohnstonJA , DworkinRH . The prevalence of chronic pain in United States adults: results of an internet-based survey . J. Pain11 ( 11 ), 1230 – 1239 ( 2010 ).